Intellia Therapeutics Shares Fall 5% After Q3 Revenue Miss
Intellia Therapeutics shares were down 5% in early trading after its Q3 revenue missed estimates.
Related stories
AEHL: trading halted on Nasdaq — volatility pause (10:39 AM ET)
Nasdaq halted trading in AEHL (volatility pause) at 10:39 AM ET.
L impact | EQUITY | Nov 05, 2026, 03:48 PM UTC
Soitec Falls 17% in Chip Rout
Soitec fell 17%, Aixtron 10% and Infineon 9% as part of a chip-sector rout.
M impact | EQUITY | Nov 05, 2026, 03:39 PM UTC
Strategic Education Shares Fall After Q3 Results Miss
Strategic Education shares fell more than 7% after its third-quarter results missed.
M impact | EQUITY | Nov 05, 2026, 03:39 PM UTC
Pegasystems Wins 10-Year US Army Contract
Pegasystems said it won a 10-year contract with the US Army to support business modernization.
M impact | EQUITY | Nov 05, 2026, 03:39 PM UTC
Cementir Holding Q3 Profit Before Tax Rises 14% to EUR 83.38 Million
M impact | EQUITY | Nov 05, 2026, 03:36 PM UTC
Beacon Announces US$50 Million Strategic Investment From Canada Pension Plan Investment Board
M impact | EQUITY | Nov 05, 2026, 03:36 PM UTC